Showing results (681-690 of 776) with videos related to
Sort By:
Pageof 78
Journal of the American Veterinary Medical Association|February 1, 2014
Vital pulp therapy in dogs: 190 cases (2001-2011)Niina Luotonen, Helena Kuntsi-Vaattovaara, Eva Sarkiala-Kessel, et al.The Journal of Biological Chemistry|July 12, 2019
Identification of functionally important residues and structural features in a bacterial lignostilbene dioxygenaseEugene Kuatsjah, Meghan M Verstraete, Marek J Kobylarz, et al.Journal of Cardiovascular Pharmacology|September 1, 1993
Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteersG A Marbet, M Verstraete, J Kienast, et al.Archives of Oral Biology|January 25, 2015
Characterization of the temporomandibular joint of the harbour porpoise (Phocoena phocoena) and Risso's dolphin (Grampus griseus)M McDonald, N Vapniarsky-Arzi, F J M Verstraete, et al.Circulation|April 1, 1989
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysisI K Jang, H K Gold, A A Ziskind, et al.Journal of the American College of Cardiology|September 1, 1990
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparationT Yasuda, H K Gold, H Yaoita, et al.Journal of the American College of Cardiology|December 1, 1990
Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibodyT Yasuda, H K Gold, R C Leinbach, et al.Circulation|September 17, 1998
Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigsO Varenne, S Pislaru, H Gillijns, et al.Circulation|October 15, 1995
A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial GroupS Vanderschueren, L Barrios, P Kerdsinchai, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activatorT H Bugge, M J Flick, M J Danton, et al.Pageof 78